BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26988939)

  • 1. Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region.
    Ebron JS; Shukla GC
    Prostate; 2016 Jun; 76(9):834-44. PubMed ID: 26988939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator.
    Jiang CY; Ruan Y; Wang XH; Zhao W; Jiang Q; Jing YF; Han BM; Xia SJ; Zhao FJ
    Mol Cell Endocrinol; 2016 May; 427():13-20. PubMed ID: 26940039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
    Kumar B; Khaleghzadegan S; Mears B; Hatano K; Kudrolli TA; Chowdhury WH; Yeater DB; Ewing CM; Luo J; Isaacs WB; Marchionni L; Lupold SE
    Oncotarget; 2016 Nov; 7(45):72593-72607. PubMed ID: 27683042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
    Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
    Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
    Bennett NC; Hooper JD; Johnson DW; Gobe GC
    Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
    Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
    Sikand K; Slaibi JE; Singh R; Slane SD; Shukla GC
    Int J Cancer; 2011 Aug; 129(4):810-9. PubMed ID: 21710544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
    Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
    Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
    Xiao J; Gong AY; Eischeid AN; Chen D; Deng C; Young CY; Chen XM
    Prostate; 2012 Oct; 72(14):1514-22. PubMed ID: 22314666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [miR-141-3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells].
    Wang C; Ouyang Y; Lu M; Wei J; Zhang H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):736-9. PubMed ID: 26062412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism.
    Xu S; Wang T; Song W; Jiang T; Zhang F; Yin Y; Jiang SW; Wu K; Yu Z; Wang C; Chen K
    Sci Rep; 2015 Aug; 5():13528. PubMed ID: 26314494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARF represses androgen receptor transactivation in prostate cancer.
    Lu W; Xie Y; Ma Y; Matusik RJ; Chen Z
    Mol Endocrinol; 2013 Apr; 27(4):635-48. PubMed ID: 23449888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
    Meng D; Yang S; Wan X; Zhang Y; Huang W; Zhao P; Li T; Wang L; Huang Y; Li T; Li Y
    Int J Biochem Cell Biol; 2016 Apr; 73():30-40. PubMed ID: 26827675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression.
    Zhao J; Zhang Y; Liu XS; Zhu FM; Xie F; Jiang CY; Zhang ZY; Gao YL; Wang YC; Li B; Xia SJ; Han BM
    Cancer Sci; 2020 Feb; 111(2):369-382. PubMed ID: 31833612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.
    Gong AY; Eischeid AN; Xiao J; Zhao J; Chen D; Wang ZY; Young CY; Chen XM
    BMC Cancer; 2012 Oct; 12():492. PubMed ID: 23095762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
    Pasqualini L; Bu H; Puhr M; Narisu N; Rainer J; Schlick B; Schäfer G; Angelova M; Trajanoski Z; Börno ST; Schweiger MR; Fuchsberger C; Klocker H
    Mol Endocrinol; 2015 Jul; 29(7):1037-54. PubMed ID: 26052614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.